Kimberly-Clark (KMB 0.14%), a consumer goods giant known for its personal care and paper-based products like Huggies and Kleenex, released its fourth-quarter earnings on January 28, 2025.
Kimberly-Clark (KMB) came out with quarterly earnings of $1.50 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.51 per share a year ago.
The company called 2024 a “breakthrough” year as it launched multiyear transformation program and rewired the business into three segments.
Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected quarterly sales on Tuesday as the Kleenex tissue maker benefited from a recovery in demand.
With the S&P 500 (^GSPC -1.46%) yield at just 1.2%, it has become more challenging to find companies or exchange-traded funds (ETFs) that can provide a steady and sizable stream of passive income. But that doesn't mean there aren't viable options if you know where to look.
KMB's Q4 results are likely to reflect a challenging consumer environment with soft demand, retail inventory reductions and currency risks.
Besides Wall Street's top -and-bottom-line estimates for Kimberly-Clark (KMB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We think that Colgate-Palmolive stock (NYSE: CL) is currently a better pick over its industry peer – Kimberly-Clark stock (NYSE: KMB). CL stock trades at 3.5x trailing revenues, versus 2.1x for KMB.
Kimberly-Clark (KMB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
While the near-term outlook remains uncertain, Kimberly-Clark's strategic efforts are likely to support sustainable growth in the medium to long term.
Kimberly-Clark de Mexico shows stronger growth prospects than its U.S. parent, and has nearly doubled its revenues over the past decade. Despite record profits, Kimberly-Clark de Mexico's stock remains undervalued at 11x earnings, offering a roughly 6.5% dividend yield. The stock's underperformance is likely due to political worries, which I believe are overblown.